SGMO vs SYY · rev $57.8M vs P/E 22, rev $84.55B
Sangamo Therapeutics Inc (SGMO) versus Sysco Corporation (SYY) — a side-by-side from cached financials, not a winner call.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Sysco Corporation (SYY) is a food distribution company listed on NYSE.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
Latest reported SYY revenue for 2026-06-27 was $84.55B. Net income was $1.76B. Revenue was up 3.9% from 2025-06-28 to 2026-06-27. SYY currently screens at market cap $37.78B and trailing P/E 21.9.
SGMO currently screens at market cap $74.6M. SYY currently screens at market cap $37.78B and trailing P/E 21.9.
Not investment advice. Open the SGMO and SYY stock pages for the full models.
Not investment advice.